A detailed history of Deutsche Bank Ag\ transactions in Cytek Biosciences, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 66,640 shares of CTKB stock, worth $430,494. This represents 0.0% of its overall portfolio holdings.

Number of Shares
66,640
Previous 56,915 17.09%
Holding current value
$430,494
Previous $317,000 16.4%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$4.73 - $6.73 $45,999 - $65,449
9,725 Added 17.09%
66,640 $369,000
Q2 2024

Aug 14, 2024

SELL
$5.3 - $6.91 $54,277 - $70,765
-10,241 Reduced 15.25%
56,915 $317,000
Q1 2024

May 15, 2024

BUY
$6.29 - $9.15 $9,762 - $14,200
1,552 Added 2.37%
67,156 $450,000
Q4 2023

Feb 14, 2024

SELL
$4.1 - $9.51 $5,157 - $11,963
-1,258 Reduced 1.88%
65,604 $598,000
Q3 2023

Nov 09, 2023

BUY
$5.52 - $9.5 $87,276 - $150,204
15,811 Added 30.97%
66,862 $369,000
Q2 2023

Aug 14, 2023

SELL
$6.69 - $11.99 $160,847 - $288,275
-24,043 Reduced 32.02%
51,051 $435,000
Q1 2023

May 15, 2023

BUY
$8.44 - $13.47 $157,296 - $251,040
18,637 Added 33.01%
75,094 $690,000
Q4 2022

Feb 13, 2023

BUY
$9.71 - $15.86 $46,510 - $75,969
4,790 Added 9.27%
56,457 $576,000
Q3 2022

Nov 14, 2022

SELL
$10.96 - $15.45 $62,746 - $88,451
-5,725 Reduced 9.98%
51,667 $761,000
Q2 2022

Aug 11, 2022

BUY
$7.41 - $11.56 $20,807 - $32,460
2,808 Added 5.14%
57,392 $616,000
Q1 2022

May 13, 2022

BUY
$9.89 - $17.25 $436,791 - $761,846
44,165 Added 423.89%
54,584 $588,000
Q4 2021

Feb 11, 2022

BUY
$16.14 - $25.04 $8,764 - $13,596
543 Added 5.5%
10,419 $170,000
Q3 2021

Nov 04, 2021

BUY
$17.52 - $27.93 $173,027 - $275,836
9,876 New
9,876 $212,000

Others Institutions Holding CTKB

About Cytek Biosciences, Inc.


  • Ticker CTKB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 134,627,008
  • Market Cap $870M
  • Description
  • Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...
More about CTKB
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.